IGMS

IGM Biosciences
IGMS

Delisted

IGMS was delisted on the 13th of August, 2025.

93 hedge funds and large institutions have $487M invested in IGM Biosciences in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+6
Holders Change %
+6.9%
% of All Funds
1.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
33
Reduced
19
Closed
21
Calls
$15M
Puts
$7.91M
Net Calls
+$7.11M
Net Calls Change
+$6.92M
Name Holding Trade Value Shares
Change
Shares
Change %
Two Sigma Advisers
101
Two Sigma Advisers
New York
-$663K -22,600 Closed
Group One Trading
102
Group One Trading
Illinois
-$357K -12,173 Closed
EAM
103
Erste Asset Management
Austria
-$189K -6,500 Closed
MIM
104
MetLife Investment Management
New Jersey
-$97.8K -3,333 Closed
Amundi
105
Amundi
France
-$50K -2,332 Closed
MLICM
106
Metropolitan Life Insurance Company (MetLife)
New York
-$67.5K -2,302 Closed
PHK
107
Point72 Hong Kong
Hong Kong
-$34K -1,149 Closed
Zurich Cantonal Bank
108
Zurich Cantonal Bank
Switzerland
-$20K -671 Closed
CAPTRUST Financial Advisors
109
CAPTRUST Financial Advisors
North Carolina
-$7K -250 Closed
PA
110
Parallel Advisors
California
-$2K -70 Closed
TFO
111
Tarbox Family Office
California
-$1K -22 Closed